rs756232589
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_001077350.3(NPRL3):βc.1707_1708delβ(p.Ter570SerfsTer82) variant causes a frameshift, stop lost change. The variant allele was found at a frequency of 0.0000168 in 1,552,074 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.000026 ( 0 hom., cov: 34)
Exomes π: 0.000016 ( 0 hom. )
Consequence
NPRL3
NM_001077350.3 frameshift, stop_lost
NM_001077350.3 frameshift, stop_lost
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.58
Genes affected
NPRL3 (HGNC:14124): (NPR3 like, GATOR1 complex subunit) Contributes to GTPase activator activity. Involved in cellular response to amino acid starvation and negative regulation of TOR signaling. Located in lysosomal membrane. Part of GATOR1 complex. Implicated in focal epilepsy. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Stoplost variant. No alternative stopcodon identified downstream, so we assume a Nonstop Mediated Decay. LoF is a known mechanism of disease.
BS2
High AC in GnomAdExome4 at 22 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPRL3 | NM_001077350.3 | c.1707_1708del | p.Ter570SerfsTer82 | frameshift_variant, stop_lost | 14/14 | ENST00000611875.5 | NP_001070818.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPRL3 | ENST00000611875.5 | c.1707_1708del | p.Ter570SerfsTer82 | frameshift_variant, stop_lost | 14/14 | 5 | NM_001077350.3 | ENSP00000478273 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152242Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
4
AN:
152242
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000624 AC: 1AN: 160136Hom.: 0 AF XY: 0.0000117 AC XY: 1AN XY: 85228
GnomAD3 exomes
AF:
AC:
1
AN:
160136
Hom.:
AF XY:
AC XY:
1
AN XY:
85228
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000157 AC: 22AN: 1399832Hom.: 0 AF XY: 0.0000174 AC XY: 12AN XY: 690404
GnomAD4 exome
AF:
AC:
22
AN:
1399832
Hom.:
AF XY:
AC XY:
12
AN XY:
690404
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152242Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74366
GnomAD4 genome
AF:
AC:
4
AN:
152242
Hom.:
Cov.:
34
AF XY:
AC XY:
3
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 05, 2023 | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); Normal stop codon changed to a serine codon, leading to the addition of 81 amino acids at the C-terminus; This variant is associated with the following publications: (PMID: 27535533) - |
Epilepsy, familial focal, with variable foci 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | This sequence change disrupts the translational stop signal of the NPRL3 mRNA. It is expected to extend the length of the NPRL3 protein by 81 additional amino acid residues. This variant is present in population databases (rs756232589, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with NPRL3-related conditions. ClinVar contains an entry for this variant (Variation ID: 542795). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at